$1.00
1 bottle (MOQ)
2- (Perfluorohexyl) Ethyl Methacrylate CAS 2144-53-8
Ningbo Samreal Chemical Co., Ltd.
Swipe or use the arrows to view product images.
Weight Loss Peptide Powder Retatrutide 99% Pure Bulk Powder Ly3437943 Triple Hormone Receptor Agonist Retatrutide for Obesity
| Price | $18.00 |
|---|---|
| Min Order | 10 vials |
| Availability | In Stock |
| Shipping From | Hubei, China |
| Popularity | 375 people viewed |
Model NO.:
Retatrutide
CAS No.:
2381089-83-2
Formula:
N/a
EINECS:
200-001-8
Type:
Synthesis Material Intermediates
Appearance:
Powder
Quality:
Refined
Colour:
White
Content:
Standard
Usage:
Laboratory Reagents
Source:
Dry Powder
Habit Appellation:
Fine Chemicals
Application:
Scientific Research
Property:
Protein and Peptide
Specific Usage:
Research Use Only
Grade:
Research Use
Name:
Retatrutide
CAS:
2381089-83-2
Note:
No Tfa Salt
From:
Authoried Regluar Workshop
Raw Powder:
1g/Bottle
Vials:
2mg 5mg 10mg 15mg
Attention:
Research Use Only
Trademark:
Hoconbio
Transport Package:
Customized
Specification:
1G/Bottle 2mg/5mg/10mg per vial
Origin:
China
Product Description
Retatrutide is a triple hormone (GIP, GLP-1 and glucagon) receptor agonist in development for the treatment of obesity.
| Product Name | Retatrutide |
| CAS NO. | 2381089-83-2 |
| Other name | LY3437943 GIPR/GLP-1R |
| Appearance | White freeze-dried powder |
| Purity | 98% HPLC |
| Application | Research peptides |
| Shelf Life | 24 Months |
| Storage | Store at a temperature of 2-8 degrees, protected from light. |
- Treatment of depression and anxiety disorders: Retatrutide has been shown to have antidepressant and anxiolytic effects in preclinical studies, suggesting that it could be a promising treatment option for individuals with these conditions.
- Prevention of neurodegenerative diseases: Retatrutide has neuroprotective properties that may be useful in preventing or slowing the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.
- Enhancement of cognitive function: Retatrutide has been shown to improve learning and memory in animal studies, suggesting that it could have potential as a cognitive enhancer in humans.
- Treatment of chronic pain: Retatrutide has been shown to have analgesic effects in preclinical studies, suggesting that it could be a useful treatment option for individuals with chronic pain conditions.
- Promotion of wound healing: Retatrutide has been shown to accelerate wound healing in animal studies, suggesting that it could have potential as a therapeutic agent for promoting wound healing in humans.
- Similar Products
Negotiable
2 Tons (MOQ)
OEM Sodium Cumenesulfonate (CAS RN: 28348-53-0)
Nanjing Datang Chemical Co., Ltd.